Stockreport

Nuvation Bio to Report First Quarter 2026 Financial Results and Provide Business Update on May 4, 2026 [TheStreet.com]

Nuvation Bio Inc. Class A  (NUVB) 
PDF PR Newswire NEW YORK, April 20, 2026 NEW YORK April 20, 2026 /PRNewswire/ -- Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of t [Read more]